Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

SIGA vs ETON: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ETON Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

ETON Overall Winner 6-Pillar Tally: SIGA 1 – 5 ETON Matrix Metrics: SIGA 3 – 7 ETON

As of Nov 19, 2026, Eton Pharmaceutcials, Inc. (ETON) is the stronger overall head-to-head candidate over SIGA Technologies Inc. (SIGA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SIGA carries a Unified Composite Score of 47.5/100 (HOLD) at $2.65 (2.5x Forward P/E, -14.2% operating margin), whereas ETON carries 34.0/100 (SELL) at $61.36 (18.6x Forward P/E, 31.3% operating margin).

  • Composite vs. Pillar Nuance: While SIGA currently prints a higher short-term Unified Composite Score (47.5/100 HOLD vs. ETON 34.0/100 SELL), ETON captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (31.3% vs. -14.2% operating margin) and revenue trajectory (+157.9% vs. -49.7% YoY).
  • Technical & Structure Timing Caution: SIGA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile ETON trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 57.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SIGA vs ETON
SIGA NASDAQ
SIGA Technologies Inc.
Pharmaceutical Preparations
$2.65
-5.36% 1D
Market Cap $187.9M
TTM Revenue $52M
Forward P/E 2.5x
Beta / 30D Vol 0.75β · 65% Vol
Unified Composite Score
47.5 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 69.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $3.02 · SMA50: $3.14
ETON NASDAQ Head-to-Head Winner
Eton Pharmaceutcials, Inc. Common Stock
Pharmaceutical Preparations
$61.36
-1.02% 1D
Market Cap $1.8B
TTM Revenue $141M
Forward P/E 18.6x
Beta / 30D Vol 0.71β · 98% Vol
Unified Composite Score
34.0 / 100 SELL
Tech 50.0 Fund 34.0 Flow 69.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 58
RSI-14: 57.8 · SMA20: $57.11 · SMA50: $55.60

6-Pillar Scorecard Institutional Category Breakdown (SIGA 1 – 5 ETON)

Columns: Metric · SIGA · ETON
1. Valuation Multiples SIGA
Forward P/E 2.5x 18.6x
Trailing P/E N/M 41.3x
PEG Ratio 3.37x N/M
EV / Revenue 1.4x 12.5x
2. Growth & Scale ETON
Revenue Growth (YoY) -49.7% +157.9%
Earnings Growth (YoY) -65.3% -12.6%
TTM Revenue (USD) $52M $141M
Market Cap $187.9M $1.8B
3. Profitability & Quality ETON
Gross Margin 23.4% 71.2%
Operating Margin -14.2% 31.3%
Net Profit Margin 1.3% 35.4%
Return on Equity (ROE) 0.4% 90.6%
4. Balance Sheet & Cash Flow ETON
Cash Generation (TTM) -$12M $20M
Cash Flow Margin -22.1% 14.2%
Net Cash / Leverage $116M Net Cash $32M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ETON
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 81.4% (8th %ile) 99.5% (31st %ile)
Put/Call OI Skew 0.04x (Call-Skewed) 0.01x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat ETON
OpEx & R&D Intensity 37.6% of Rev ($20M) 39.9% of Rev ($56M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Drug Manufacturers - Specialty & Generic Operator Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SIGA (3) vs ETON (7)
Institutional Metric SIGA ETON Criterion Row Edge
Market Capitalization
Scale
$187.9M $1.8B Larger Scale ETON
Trailing P/E Ratio
Valuation
N/M 41.3x Lower Multiple ETON
Forward P/E Ratio
Valuation
2.5x 18.6x Lower Multiple SIGA
Revenue Growth (YoY)
Growth
-49.7% +157.9% Higher Growth ETON
Operating Margin (TTM)
Profitability
-14.2% 31.3% Higher Margin ETON
Net Profit Margin
Profitability
1.3% 35.4% Higher Margin ETON
Return on Equity (ROE)
Capital Efficiency
0.4% 90.6% Higher ROE ETON
52-Week Range Position
Momentum
3% ($3–$7) 84% ($14–$71) Stronger Trend ETON
Beta / 30D Volatility
Risk Regime
0.75β · 65% Vol 0.71β · 98% Vol Lower Realized Risk SIGA
Unified Institutional Score
Composite Signal
47.5 / 100 (HOLD) 34.0 / 100 (SELL) Higher Composite SIGA
Trailing 12M Revenue (USD)
Operating Scale
$52M $141M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
23.4% 71.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.37x PEG · 1.4x EV/Rev N/M PEG · 12.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$12M ($116M Net Cash) $20M ($32M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ETON +39.52 pp
SIGA: -15.06% · ETON: +24.46%
3M Horizon ETON +9.51 pp
SIGA: -12.83% · ETON: -3.32%
6M Horizon ETON +119.05 pp
SIGA: -43.74% · ETON: +75.31%
1Y Horizon ETON +312.35 pp
SIGA: -55.61% · ETON: +256.74%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period SIGA Revenue ETON Revenue SIGA Op. Margin ETON Op. Margin Margin Leader
FY2018 $480M N/A 74.4% N/A SIGA
FY2019 $30M $0M -8.7% -1939.6% SIGA
FY2020 $120M $0M 67.6% -69515.4% SIGA
FY2021 $130M $20M 66.7% -6.8% SIGA
FY2022 $110M $20M 38.5% -38.9% SIGA
FY2023 $140M $30M 59.8% -3.8% SIGA
FY2024 $140M $40M 50.4% -6.7% SIGA
FY2025 $90M $80M 25.1% -1.1% SIGA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SIGA CONSOLIDATION
33d in phase · OBV DISTRIBUTION
Current IV 81.4%
IV Percentile 8th %ile
Put/Call OI Skew 0.04x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SIGA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ETON CONSOLIDATION
62d in phase · OBV NEUTRAL
Current IV 99.5%
IV Percentile 31st %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ETON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SIGA Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $187.9M market capitalization and -14.2% operating margin.
OpEx & R&D Reinvestment 37.6% of Rev ($20M)
90D Engineering Disclosures 0 Published
ETON Moat Profile High-Margin Pricing Power Moat
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $1.8B market capitalization and 31.3% operating margin.
OpEx & R&D Reinvestment 39.9% of Rev ($56M)
90D Engineering Disclosures 0 Published

Investor FAQ SIGA vs ETON Key Questions & Quantitative Answers

As of Nov 19, 2026, Eton Pharmaceutcials, Inc. (ETON) is the stronger overall head-to-head candidate over SIGA Technologies Inc. (SIGA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SIGA carries a Unified Composite Score of 47.5/100 (HOLD) at $2.65 (2.5x Forward P/E, -14.2% operating margin), whereas ETON carries 34.0/100 (SELL) at $61.36 (18.6x Forward P/E, 31.3% operating margin). Composite vs. Pillar Nuance: While SIGA currently prints a higher short-term Unified Composite Score (47.5/100 HOLD vs. ETON 34.0/100 SELL), ETON captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (31.3% vs. -14.2% operating margin) and revenue trajectory (+157.9% vs. -49.7% YoY). Technical & Structure Timing Caution: SIGA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile ETON trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 57.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ETON leads the Growth & Scale pillar: SIGA posts -49.7% YoY revenue growth and -65.3% YoY earnings growth on $52M TTM revenue (23.4% gross margin, -14.2% operating margin), compared with ETON at +157.9% YoY revenue growth and -12.6% YoY earnings growth on $141M TTM revenue (71.2% gross margin, 31.3% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SIGA cumulative revenue shifted -81.2% while ETON shifted +300.0%. In operating R&D and SG&A reinvestment, SIGA deploys 37.6% of Rev ($20M) (0 90-day corporate R&D disclosures) versus 39.9% of Rev ($56M) (0 disclosures) for ETON.

SIGA screens cheaper on headline valuation multiples. SIGA trades at 2.5x Forward P/E, N/M Trailing P/E, 3.37x PEG, and 1.4x EV/Revenue (-22.1% FCF margin), whereas ETON trades at 18.6x Forward P/E, 41.3x Trailing P/E, N/M PEG, and 12.5x EV/Revenue (14.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SIGA (0.4% ROE) versus ETON (90.6% ROE) capital efficiency.

In options market volatility and institutional positioning, SIGA carries 81.4% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.75β · 65% Vol realized risk). By comparison, ETON carries 99.5% implied volatility (31st %ile, Balanced (25th–60th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.71β · 98% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.